Evidence map›Paper›PMID 37468247›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Multidrug-resistant IgA Vasculitis with Gastrointestinal Symptoms Successfully Treated with Intravenous Cyclophosphamide and Maintained with Mycophenolate Mofetil.

Haruka Miki, Hiroto Tsuboi, Fumina Kawashima, Toshiki Sugita, Taihei Nishiyama, Yuki Kuroda, Tomonori Sawabe, Nana Uematsu, Mayu Terasaki, Ayako Kitada and 7 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Haruka MikiDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Hiroto TsuboiDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Fumina KawashimaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Toshiki SugitaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Taihei NishiyamaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Yuki KurodaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Tomonori SawabeDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Nana UematsuDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Mayu TerasakiDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Ayako KitadaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Fumika HondaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Ayako OhyamaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Mizuki YagishitaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Hiromitsu AsashimaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Shinya HagiwaraDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Yuya KondoDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
Isao MatsumotoDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Japan.
University of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the case of a 17-year-old woman with IgA vasculitis (IgAV) who presented with relapsing gastrointestinal (GI) symptoms that were refractory to glucocorticoid and combination therapy with cyclosporine A, azathioprine or mycophenolate mofetil (MMF). The patient responded well to remission induction with intravenous cyclophosphamide (IVCY) and was successfully maintained with MMF. Remission induction with IVCY followed by maintenance therapy with MMF was effective in a patient with multidrug-resistant IgAV with GI lesions.

Indexed as

IgA VasculitisLupus NephritisAdolescentAzathioprineCyclophosphamideFemaleHumansImmunosuppressive AgentsMycophenolic AcidRemission InductionAzathioprineCyclophosphamideImmunosuppressive AgentsMycophenolic Acidcase reportGI involvementIgA vasculitisintravenous cyclophosphamide (IVCY)mycophenolate mofetil (MMF)

Identifiers

PMID37468247
PMCPMC10982010
OpenAlexW4384785137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.